Keywords
Herpesvirus 8, Human
Colombia
How to Cite
Abstract
Kaposi’s sarcoma is a low-grade vascular tumor that affects the skin and mucous membranes and may compromise lymph nodes and internal organs. It is usually associated with human herpes virus infection 8, classified into four clinical-epidemiological subtypes, including the classical type, which is usually manifested in elderly, immunocompetent white Jews or of Mediterranean origin. We present the case of a 69-year-old male, with phototype VI, who initially developed violaceous macules, erythematous, with defined border in the external region of the left foot, which progressively turned to violet plaques and nodules, accompanied by edema. A biopsy was performed showing vascular lesion, whose immunohistochemistry presented reactivity for CD30, CD34 and human herpesvirus 8, confirming a Kaposi’s sarcoma in the nodule phase. This case is exceptional and must be kept in mind in the differential diagnosis; the reports in South America are scarce, being the first in Colombia. MÉD.UIS. 2017;30(3):129-33.
References
2. Dittmer DP, Blossom D. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV) - an update. Curr Opin Virol. 2013;3:238-44.
3. García A, Olivella F, Valderrama S, Rodríguez G. Kaposi´s sarcoma in Colombia. Cancer Cytopathol. 1989;64(11):2393-8.
4. Rojo A. Sarcoma de Kaposi: revisión de la literatura e ilustración de un caso. Acta Médica Grupo Ángeles. 2013;11(1):23-31. Disponible en: http://www.medigraphic.com/actamedica
5. Enzinger FM, Weiss SW. Malignant vascular tumors. En: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors 3.ª ed. St. Louis: C.V. Mosby Co, 1995:641-77.
6. Hiatt KM, Nelson AM, Lichy JH, Fanburg-Smith JC. Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma. Mod Pathol. 2008;21(5):572-82.
7. Cioffi A, Reichert S, Antonescu CR, Maki RG. Angiosarcomas and other sarcomas of endothelial origin. Hematol Oncol Clin N Am. 2013;27(5):975-88.
8. Rohner E, Wyss N, Trelle S, Mbulaiteye SM, Egger M, Novak U, et al. HHV-8 seroprevalence: A global view. Syst Rev. 2014;(12):3-11.
9. Taddeo A, Presicce P, Brambilla L, Bellinvia M, Villa ML, Della Bella S. Circulating endothelial progenitor cells are increased in patients with classic Kaposi’s sarcoma. J Invest Dermatol. 2008; 128(8):2125-8.
10. Mohanna S, Maco V, Bravo F, Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: A critical review of an old disease. Int J Infect Dis. 2005;9(5):239-50.
11. Montibeler R, Oliveira AL, Martins L, Almeida E. Kaposi’s Sarcoma: clinical and pathological aspects in patients seen at the Hospital Universitário Cassiano Antônio Moraes - Vitória -Espírito Santo - Brazil. An Bras Dermatol. 2012;87(2):220-7.
12. Carvalho IM, Garção F, Abrahão L, Salaro CP, Carvalho RM. Classic Kaposi’s sarcoma: a case report. An Bras Dermatol. 2001;76(2):195-9.
13. Brambilla L, Boneschi V, Taglioni M, Ferrucci S. Staging of classic Kaposi’s sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2003;13(1):83-6.
14. Jiménez K, Martínez JD, Hernández G, Garzón MA, Hormaza N, Lizarazo JI. et al. Tres variedades de sarcoma de Kaposi con compromiso gastrointestinal. Rev Col Gastroenterol. 2015;30(3):342-6.
15. Régnier-Rosencher E, Guillot B, Dupin N. Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol. 2013;68(2):313-31.